Misoprostol

US-MEC 2024 update, NuvaRing for adenomyosis, COCs & psychotropic meds, abortion bans & maternal health, adolescent abortion info

Review of evidence-based, person-centered strategies for improving patient comfort during IUD placements, from paracervical blocks to non-medication supports

LNG IUD as EC, IUD pain management, thrombosis risks with hormonal contraception, telehealth & medication abortion, adolescent contraception guidance

Partner treatment for BV, pain and bleeding experiences during first-trimester abortion, interest in Rh testing and treatment for telehealth medication abortion.

Double dosing UPA for EC not needed for BMI > 30, postpartum implant placement and milk supply, mifepristone to increase efficacy of medication management of EPL.

Clinical guidance on early pregnancy loss and SMA, safety of outpatient abortion for people with higher body weights, and how to document first-trimester ultrasound findings.

Clinical trial data on a new IUD, clinical guidance on self-managed abortion, the impact of the ACA on reproductive health, and CDC’s abortion surveillance data.

Answers for healthcare providers on routes of misoprostol administration and what they mean for medication abortion care.